Skip to main content

Market Overview

Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy

Share:
Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy
  • Motus GI Holdings Inc (NASDAQ: MOTS) has submitted a 510(k) application to the FDA for a version of the Pure-Vu System.
  • The new version of the system is compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots, and debris to provide a clear field-of-view for the endoscopist.
  • Price Action: MOTS shares are down 2.45% at $1.20 on the last check Tuesday.
 

Related Articles (MOTS)

View Comments and Join the Discussion!

Posted-In: Briefs endoscopyBiotech News Penny Stocks Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com